nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS2—Lenalidomide—hematologic cancer	0.0811	0.0917	CbGbCtD
Lumiracoxib—UGT1A9—Irinotecan—hematologic cancer	0.0462	0.0523	CbGbCtD
Lumiracoxib—CYP1A2—Anagrelide—hematologic cancer	0.0441	0.0499	CbGbCtD
Lumiracoxib—PTGS2—Thalidomide—hematologic cancer	0.0433	0.049	CbGbCtD
Lumiracoxib—PTGS1—Bortezomib—hematologic cancer	0.042	0.0475	CbGbCtD
Lumiracoxib—PTGS1—Thalidomide—hematologic cancer	0.0366	0.0414	CbGbCtD
Lumiracoxib—PTGS1—Ifosfamide—hematologic cancer	0.0322	0.0364	CbGbCtD
Lumiracoxib—PTGS1—Imatinib—hematologic cancer	0.0307	0.0348	CbGbCtD
Lumiracoxib—PTGS2—Triamcinolone—hematologic cancer	0.03	0.034	CbGbCtD
Lumiracoxib—CYP2C9—Bexarotene—hematologic cancer	0.0276	0.0312	CbGbCtD
Lumiracoxib—PTGS2—Betamethasone—hematologic cancer	0.0257	0.0291	CbGbCtD
Lumiracoxib—CYP1A2—Carmustine—hematologic cancer	0.0232	0.0262	CbGbCtD
Lumiracoxib—CYP2C9—Idarubicin—hematologic cancer	0.0228	0.0258	CbGbCtD
Lumiracoxib—CYP2C19—Bortezomib—hematologic cancer	0.0203	0.023	CbGbCtD
Lumiracoxib—CYP1A2—Methoxsalen—hematologic cancer	0.0197	0.0223	CbGbCtD
Lumiracoxib—CYP1A2—Bortezomib—hematologic cancer	0.0187	0.0212	CbGbCtD
Lumiracoxib—PTGS2—Cisplatin—hematologic cancer	0.0185	0.021	CbGbCtD
Lumiracoxib—PTGS2—Etoposide—hematologic cancer	0.0182	0.0206	CbGbCtD
Lumiracoxib—CYP1A2—Daunorubicin—hematologic cancer	0.0179	0.0203	CbGbCtD
Lumiracoxib—CYP2C19—Thalidomide—hematologic cancer	0.0177	0.02	CbGbCtD
Lumiracoxib—CYP1A2—Alitretinoin—hematologic cancer	0.0176	0.0199	CbGbCtD
Lumiracoxib—CYP2C9—Bortezomib—hematologic cancer	0.0169	0.0191	CbGbCtD
Lumiracoxib—CYP2C19—Teniposide—hematologic cancer	0.0169	0.0191	CbGbCtD
Lumiracoxib—CYP1A2—Thalidomide—hematologic cancer	0.0163	0.0185	CbGbCtD
Lumiracoxib—CYP2C19—Ifosfamide—hematologic cancer	0.0156	0.0176	CbGbCtD
Lumiracoxib—PTGS1—Etoposide—hematologic cancer	0.0154	0.0174	CbGbCtD
Lumiracoxib—PTGS2—Dexamethasone—hematologic cancer	0.015	0.0169	CbGbCtD
Lumiracoxib—CYP2C19—Imatinib—hematologic cancer	0.0149	0.0168	CbGbCtD
Lumiracoxib—CYP2C9—Thalidomide—hematologic cancer	0.0147	0.0167	CbGbCtD
Lumiracoxib—CYP1A2—Dacarbazine—hematologic cancer	0.014	0.0159	CbGbCtD
Lumiracoxib—CYP2C9—Teniposide—hematologic cancer	0.014	0.0159	CbGbCtD
Lumiracoxib—CYP1A2—Imatinib—hematologic cancer	0.0137	0.0155	CbGbCtD
Lumiracoxib—CYP2C9—Ifosfamide—hematologic cancer	0.013	0.0147	CbGbCtD
Lumiracoxib—CYP2C9—Imatinib—hematologic cancer	0.0124	0.014	CbGbCtD
Lumiracoxib—CYP2C9—Nilotinib—hematologic cancer	0.0112	0.0127	CbGbCtD
Lumiracoxib—CYP1A2—Dasatinib—hematologic cancer	0.011	0.0125	CbGbCtD
Lumiracoxib—CYP2C19—Prednisone—hematologic cancer	0.00981	0.0111	CbGbCtD
Lumiracoxib—CYP1A2—Etoposide—hematologic cancer	0.00687	0.00778	CbGbCtD
Lumiracoxib—CYP2C9—Cisplatin—hematologic cancer	0.0063	0.00713	CbGbCtD
Lumiracoxib—CYP2C19—Dexamethasone—hematologic cancer	0.00612	0.00693	CbGbCtD
Lumiracoxib—CYP2C9—Dexamethasone—hematologic cancer	0.00509	0.00576	CbGbCtD
Lumiracoxib—PTGS2—ovarian follicle—hematologic cancer	0.00447	0.377	CbGeAlD
Lumiracoxib—Meclofenamic acid—ALOX5—hematologic cancer	0.00141	0.34	CrCbGaD
Lumiracoxib—Tolmetin—MPO—hematologic cancer	0.000921	0.223	CrCbGaD
Lumiracoxib—CYP2C19—hematopoietic system—hematologic cancer	0.000798	0.0673	CbGeAlD
Lumiracoxib—Diclofenac—ALOX5—hematologic cancer	0.000787	0.19	CrCbGaD
Lumiracoxib—Diclofenac—UGT1A1—hematologic cancer	0.000691	0.167	CrCbGaD
Lumiracoxib—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000658	0.209	CbGdCrCtD
Lumiracoxib—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000658	0.209	CbGdCrCtD
Lumiracoxib—CYP1A2—hematopoietic system—hematologic cancer	0.000652	0.0549	CbGeAlD
Lumiracoxib—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000642	0.205	CbGdCrCtD
Lumiracoxib—CYP2C9—hematopoietic system—hematologic cancer	0.000619	0.0522	CbGeAlD
Lumiracoxib—PTGS1—hematopoietic system—hematologic cancer	0.000565	0.0476	CbGeAlD
Lumiracoxib—PTGS2—hematopoietic system—hematologic cancer	0.00054	0.0455	CbGeAlD
Lumiracoxib—CYP2C19—blood—hematologic cancer	0.000529	0.0446	CbGeAlD
Lumiracoxib—CYP1A2—blood—hematologic cancer	0.000432	0.0364	CbGeAlD
Lumiracoxib—CYP2C9—blood—hematologic cancer	0.00041	0.0346	CbGeAlD
Lumiracoxib—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000397	0.126	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000397	0.126	CbGdCrCtD
Lumiracoxib—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000388	0.124	CbGdCrCtD
Lumiracoxib—CYP1A2—lung—hematologic cancer	0.000379	0.0319	CbGeAlD
Lumiracoxib—PTGS1—blood—hematologic cancer	0.000374	0.0315	CbGeAlD
Lumiracoxib—PTGS2—blood—hematologic cancer	0.000358	0.0302	CbGeAlD
Lumiracoxib—PTGS2—bone marrow—hematologic cancer	0.000346	0.0292	CbGeAlD
Lumiracoxib—PTGS1—lung—hematologic cancer	0.000328	0.0277	CbGeAlD
Lumiracoxib—PTGS2—lung—hematologic cancer	0.000314	0.0264	CbGeAlD
Lumiracoxib—PTGS1—testis—hematologic cancer	0.00031	0.0261	CbGeAlD
Lumiracoxib—PTGS1—lymph node—hematologic cancer	0.000224	0.0189	CbGeAlD
Lumiracoxib—PTGS2—lymph node—hematologic cancer	0.000215	0.0181	CbGeAlD
Lumiracoxib—Diclofenac—ALB—hematologic cancer	0.000169	0.0409	CrCbGaD
Lumiracoxib—Diclofenac—ABCB1—hematologic cancer	0.000162	0.0391	CrCbGaD
Lumiracoxib—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.26e-05	0.00013	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AGRN—hematologic cancer	1.26e-05	0.000129	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT1—hematologic cancer	1.25e-05	0.000129	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.23e-05	0.000127	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.23e-05	0.000126	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—UGT1A1—hematologic cancer	1.22e-05	0.000126	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTP1—hematologic cancer	1.21e-05	0.000125	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—MTHFR—hematologic cancer	1.21e-05	0.000124	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—IDH1—hematologic cancer	1.2e-05	0.000123	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HMMR—hematologic cancer	1.19e-05	0.000123	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—IDH2—hematologic cancer	1.19e-05	0.000123	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC22A1—hematologic cancer	1.19e-05	0.000122	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CRABP1—hematologic cancer	1.19e-05	0.000122	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—TXN—hematologic cancer	1.19e-05	0.000122	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.19e-05	0.000122	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.19e-05	0.000122	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.17e-05	0.000121	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—GRB2—hematologic cancer	1.17e-05	0.00012	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PDGFA—hematologic cancer	1.17e-05	0.00012	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.16e-05	0.000119	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALOX5—hematologic cancer	1.16e-05	0.000119	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NQO1—hematologic cancer	1.16e-05	0.000119	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CD44—hematologic cancer	1.16e-05	0.000119	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KITLG—hematologic cancer	1.15e-05	0.000118	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ABCB1—hematologic cancer	1.15e-05	0.000118	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.13e-05	0.000116	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.13e-05	0.000116	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT5A—hematologic cancer	1.12e-05	0.000116	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NUP98—hematologic cancer	1.12e-05	0.000116	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ARNTL—hematologic cancer	1.12e-05	0.000115	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.12e-05	0.000115	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—GSTM1—hematologic cancer	1.12e-05	0.000115	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NCOR1—hematologic cancer	1.12e-05	0.000115	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN2B—hematologic cancer	1.11e-05	0.000115	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CYCS—hematologic cancer	1.09e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ACP5—hematologic cancer	1.09e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CA9—hematologic cancer	1.09e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ADCY7—hematologic cancer	1.09e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NCOA3—hematologic cancer	1.09e-05	0.000112	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.09e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.09e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.09e-05	0.000112	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NUP214—hematologic cancer	1.08e-05	0.000111	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD86—hematologic cancer	1.08e-05	0.000111	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOR2—hematologic cancer	1.08e-05	0.000111	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.07e-05	0.00011	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.07e-05	0.00011	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HES1—hematologic cancer	1.06e-05	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTR—hematologic cancer	1.06e-05	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ABCG2—hematologic cancer	1.06e-05	0.000109	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.06e-05	0.000109	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NCOR1—hematologic cancer	1.06e-05	0.000109	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGF1—hematologic cancer	1.05e-05	0.000107	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ENO2—hematologic cancer	1.04e-05	0.000107	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FOXO1—hematologic cancer	1.03e-05	0.000106	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PDGFRB—hematologic cancer	1.03e-05	0.000106	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—IDH1—hematologic cancer	1.03e-05	0.000105	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NUP98—hematologic cancer	1.03e-05	0.000105	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CG—hematologic cancer	1.02e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—TXN—hematologic cancer	1.01e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTO1—hematologic cancer	1.01e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCC3—hematologic cancer	1.01e-05	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PDGFRA—hematologic cancer	1.01e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTT1—hematologic cancer	1.01e-05	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—JAK1—hematologic cancer	1.01e-05	0.000104	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PRKCG—hematologic cancer	1.01e-05	0.000104	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ADCY7—hematologic cancer	9.95e-06	0.000102	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NCOA3—hematologic cancer	9.95e-06	0.000102	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.94e-06	0.000102	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SPHK1—hematologic cancer	9.93e-06	0.000102	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NUP214—hematologic cancer	9.88e-06	0.000102	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SDC1—hematologic cancer	9.87e-06	0.000101	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—hematologic cancer	9.86e-06	0.000101	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	9.78e-06	0.0001	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.78e-06	0.0001	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTR—hematologic cancer	9.68e-06	9.95e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCG2—hematologic cancer	9.68e-06	9.95e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTP1—hematologic cancer	9.64e-06	9.9e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—UGT1A1—hematologic cancer	9.54e-06	9.8e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ENO2—hematologic cancer	9.49e-06	9.76e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.43e-06	9.69e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—CREBBP—hematologic cancer	9.42e-06	9.68e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—hematologic cancer	9.35e-06	9.6e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	9.32e-06	9.58e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HLA-A—hematologic cancer	9.32e-06	9.58e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TERT—hematologic cancer	9.32e-06	9.58e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.31e-06	9.56e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC22A1—hematologic cancer	9.28e-06	9.54e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CRABP1—hematologic cancer	9.28e-06	9.54e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTT1—hematologic cancer	9.21e-06	9.46e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ABCB1—hematologic cancer	9.12e-06	9.37e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PDGFB—hematologic cancer	9.1e-06	9.35e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	9.07e-06	9.32e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALOX5—hematologic cancer	9.04e-06	9.29e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SDC1—hematologic cancer	9e-06	9.25e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CD—hematologic cancer	8.93e-06	9.18e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.9e-06	9.15e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TSC2—hematologic cancer	8.89e-06	9.14e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NCOR1—hematologic cancer	8.86e-06	9.1e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTM1—hematologic cancer	8.86e-06	9.1e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—hematologic cancer	8.82e-06	9.06e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NUP98—hematologic cancer	8.76e-06	9e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.69e-06	8.93e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	8.6e-06	8.83e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGFR3—hematologic cancer	8.55e-06	8.79e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ADCY7—hematologic cancer	8.5e-06	8.74e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOA3—hematologic cancer	8.5e-06	8.74e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	8.49e-06	8.72e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NUP214—hematologic cancer	8.44e-06	8.68e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3R1—hematologic cancer	8.44e-06	8.67e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CD44—hematologic cancer	8.39e-06	8.62e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NQO1—hematologic cancer	8.39e-06	8.62e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.36e-06	8.59e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CG—hematologic cancer	8.28e-06	8.51e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTR—hematologic cancer	8.27e-06	8.5e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCG2—hematologic cancer	8.27e-06	8.5e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.22e-06	8.44e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.12e-06	8.34e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ENO2—hematologic cancer	8.11e-06	8.34e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BAD—hematologic cancer	8.11e-06	8.33e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOTCH1—hematologic cancer	8.03e-06	8.25e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYCS—hematologic cancer	7.94e-06	8.16e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	7.89e-06	8.11e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTT1—hematologic cancer	7.87e-06	8.09e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD80—hematologic cancer	7.87e-06	8.08e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KIT—hematologic cancer	7.85e-06	8.07e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—hematologic cancer	7.83e-06	8.04e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CB—hematologic cancer	7.79e-06	8e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.75e-06	7.96e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTPN11—hematologic cancer	7.71e-06	7.93e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SDC1—hematologic cancer	7.69e-06	7.9e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CREBBP—hematologic cancer	7.68e-06	7.89e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NQO1—hematologic cancer	7.65e-06	7.86e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CD44—hematologic cancer	7.65e-06	7.86e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	7.49e-06	7.7e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CREB1—hematologic cancer	7.47e-06	7.68e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BRAF—hematologic cancer	7.38e-06	7.58e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.35e-06	7.55e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6R—hematologic cancer	7.29e-06	7.49e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CD—hematologic cancer	7.28e-06	7.48e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CREBBP—hematologic cancer	7.28e-06	7.48e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.25e-06	7.45e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYCS—hematologic cancer	7.24e-06	7.44e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	7.19e-06	7.39e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—hematologic cancer	7.19e-06	7.39e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.1e-06	7.3e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTP1—hematologic cancer	7e-06	7.19e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAP2K1—hematologic cancer	6.95e-06	7.14e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.94e-06	7.13e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CD—hematologic cancer	6.9e-06	7.09e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.9e-06	7.09e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3R1—hematologic cancer	6.88e-06	7.07e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.77e-06	6.96e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—hematologic cancer	6.73e-06	6.91e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ABCB1—hematologic cancer	6.63e-06	6.81e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGF2—hematologic cancer	6.61e-06	6.79e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CG—hematologic cancer	6.58e-06	6.76e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NQO1—hematologic cancer	6.54e-06	6.72e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CD44—hematologic cancer	6.54e-06	6.72e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3R1—hematologic cancer	6.52e-06	6.7e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	6.47e-06	6.65e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTM1—hematologic cancer	6.43e-06	6.61e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NCOR1—hematologic cancer	6.43e-06	6.61e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—EP300—hematologic cancer	6.42e-06	6.59e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.4e-06	6.58e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTP1—hematologic cancer	6.38e-06	6.56e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CB—hematologic cancer	6.35e-06	6.52e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—JAK2—hematologic cancer	6.34e-06	6.51e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYCS—hematologic cancer	6.19e-06	6.36e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MDM2—hematologic cancer	6.18e-06	6.35e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.17e-06	6.35e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	6.15e-06	6.32e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CREBBP—hematologic cancer	6.1e-06	6.27e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.04e-06	6.21e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CB—hematologic cancer	6.02e-06	6.18e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTOR—hematologic cancer	6.02e-06	6.18e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—hematologic cancer	6.01e-06	6.17e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTM1—hematologic cancer	5.86e-06	6.03e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NCOR1—hematologic cancer	5.86e-06	6.03e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CD—hematologic cancer	5.78e-06	5.94e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—hematologic cancer	5.71e-06	5.86e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—hematologic cancer	5.68e-06	5.84e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1B—hematologic cancer	5.65e-06	5.8e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.53e-06	5.69e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—hematologic cancer	5.48e-06	5.64e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3R1—hematologic cancer	5.46e-06	5.61e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTP1—hematologic cancer	5.45e-06	5.6e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.28e-06	5.42e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—EP300—hematologic cancer	5.23e-06	5.38e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1A—hematologic cancer	5.21e-06	5.35e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—hematologic cancer	5.2e-06	5.34e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.18e-06	5.33e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCB1—hematologic cancer	5.16e-06	5.31e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CB—hematologic cancer	5.04e-06	5.18e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOR1—hematologic cancer	5.01e-06	5.15e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTM1—hematologic cancer	5.01e-06	5.15e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.01e-06	5.15e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EP300—hematologic cancer	4.96e-06	5.1e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SRC—hematologic cancer	4.82e-06	4.95e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CG—hematologic cancer	4.78e-06	4.91e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CA—hematologic cancer	4.75e-06	4.88e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—STAT3—hematologic cancer	4.65e-06	4.78e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NRAS—hematologic cancer	4.64e-06	4.77e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.57e-06	4.69e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MAPK3—hematologic cancer	4.44e-06	4.57e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—hematologic cancer	4.43e-06	4.55e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CREBBP—hematologic cancer	4.43e-06	4.55e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.35e-06	4.48e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—hematologic cancer	4.35e-06	4.47e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MYC—hematologic cancer	4.32e-06	4.44e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—hematologic cancer	4.31e-06	4.43e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CD—hematologic cancer	4.2e-06	4.31e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—EP300—hematologic cancer	4.15e-06	4.27e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—hematologic cancer	4.14e-06	4.26e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.04e-06	4.15e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KRAS—hematologic cancer	3.99e-06	4.1e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3R1—hematologic cancer	3.96e-06	4.07e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.9e-06	4.01e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—AKT1—hematologic cancer	3.88e-06	3.98e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CA—hematologic cancer	3.87e-06	3.98e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CD—hematologic cancer	3.83e-06	3.93e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALB—hematologic cancer	3.78e-06	3.88e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.72e-06	3.82e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CA—hematologic cancer	3.67e-06	3.77e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CB—hematologic cancer	3.66e-06	3.76e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3R1—hematologic cancer	3.62e-06	3.71e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CREBBP—hematologic cancer	3.45e-06	3.55e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HRAS—hematologic cancer	3.39e-06	3.49e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.34e-06	3.43e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CD—hematologic cancer	3.27e-06	3.36e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—hematologic cancer	3.25e-06	3.34e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—hematologic cancer	3.23e-06	3.32e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—hematologic cancer	3.16e-06	3.25e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—hematologic cancer	3.16e-06	3.25e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3R1—hematologic cancer	3.09e-06	3.17e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CA—hematologic cancer	3.07e-06	3.16e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—EP300—hematologic cancer	3.02e-06	3.1e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—hematologic cancer	3e-06	3.08e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—hematologic cancer	2.88e-06	2.96e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.85e-06	2.93e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—EP300—hematologic cancer	2.75e-06	2.83e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—hematologic cancer	2.51e-06	2.58e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—hematologic cancer	2.46e-06	2.53e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—EP300—hematologic cancer	2.35e-06	2.41e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CA—hematologic cancer	2.23e-06	2.29e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.03e-06	2.09e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—hematologic cancer	1.82e-06	1.87e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.74e-06	1.79e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—hematologic cancer	1.66e-06	1.71e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—hematologic cancer	1.42e-06	1.46e-05	CbGpPWpGaD
